Germline mutations in TMEM127 confer susceptibility to pheochromocytoma-Reference-Cited by-同舟云学术

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

Published:2010-02-14 Issue:3 Volume:42 Page:229-233
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Qin Yuejuan,Yao Li,King Elizabeth E,Buddavarapu Kalyan,Lenci Romina E,Chocron E Sandra,Lechleiter James D,Sass Meghan,Aronin Neil,Schiavi Francesca,Boaretto Francesca,Opocher Giuseppe,Toledo Rodrigo A,Toledo Sergio P A,Stiles Charles,Aguiar Ricardo C T,Dahia Patricia L M

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.533.pdf

Reference29 articles.

1. Amar, L. et al. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23, 8812–8818 (2005).

2. Dahia, P.L. Evolving concepts in pheochromocytoma and paraganglioma. Curr. Opin. Oncol. 18, 1–8 (2006).

3. Dahia, P.L.M. et al. Novel pheochromocytoma susceptibility loci identified by integrative genomics. Cancer Res. 65, 9651–9658 (2005).

4. Sjöblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274 (2006).

5. Neumann, H.P. et al. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346, 1459–1466 (2002).

Cited by 342 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular genetics of pheochromocytoma/paraganglioma;Current Opinion in Endocrine and Metabolic Research;2024-09

2. Management of metastatic pheochromocytomas and paragangliomas: when and what;Current Problems in Cancer;2024-08

3. Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics;ELIFE;2024

4. Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics;eLife;2024-04-30

5. Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics;2024-03-22